108 related articles for article (PubMed ID: 32081704)
1. Efficient refolding and reconstitution of tissue factor into nanodiscs facilitates structural investigation of a multicomponent system on a lipid bilayer.
Tidemand FG; Østergaard H; Ploug M; Kragelund BB; Arleth L
Biochim Biophys Acta Biomembr; 2020 Jun; 1862(6):183214. PubMed ID: 32081704
[TBL] [Abstract][Full Text] [Related]
2. Structural modulation of factor VIIa by full-length tissue factor (TF
Prasad R; Sen P
J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
[TBL] [Abstract][Full Text] [Related]
3. Tissue Factor Residues That Modulate Magnesium-Dependent Rate Enhancements of the Tissue Factor/Factor VIIa Complex.
Gajsiewicz JM; Nuzzio KM; Rienstra CM; Morrissey JH
Biochemistry; 2015 Aug; 54(30):4665-71. PubMed ID: 26169722
[TBL] [Abstract][Full Text] [Related]
4. Structural model of tissue factor (TF) and TF-factor VIIa complex in a lipid membrane: A combined experimental and computational study.
Luchini A; Tidemand FG; Araya-Secchi R; Campana M; Cárdenas M; Arleth L
J Colloid Interface Sci; 2022 Oct; 623():294-305. PubMed ID: 35594588
[TBL] [Abstract][Full Text] [Related]
5. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
[TBL] [Abstract][Full Text] [Related]
6. Analysis of factor VIIa binding to relipidated tissue factor by surface plasmon resonance.
Sen P; Neuenschwander PF; Pendurthi UR; Rao LV
Blood Coagul Fibrinolysis; 2010 Jun; 21(4):376-9. PubMed ID: 20305542
[TBL] [Abstract][Full Text] [Related]
7. Contribution of allosteric disulfide in the structural regulation of membrane-bound tissue factor-factor VIIa binary complex.
Prasad R; Banerjee S; Sen P
J Biomol Struct Dyn; 2019 Sep; 37(14):3707-3720. PubMed ID: 30238846
[TBL] [Abstract][Full Text] [Related]
8. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
Stone MD; Harvey SB; Martinez MB; Bach RR; Nelsestuen GL
Biochemistry; 2005 Apr; 44(16):6321-30. PubMed ID: 15835921
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor residues Lys165 and Lys166 are essential for rapid formation of the quaternary complex of tissue factor.VIIa with Xa.tissue factor pathway inhibitor.
Rao LV; Ruf W
Biochemistry; 1995 Aug; 34(34):10867-71. PubMed ID: 7662667
[TBL] [Abstract][Full Text] [Related]
10. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
Prasad R; Sen P
Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
[TBL] [Abstract][Full Text] [Related]
11. Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor.
Ohkubo YZ; Morrissey JH; Tajkhorshid E
J Thromb Haemost; 2010 May; 8(5):1044-53. PubMed ID: 20180816
[TBL] [Abstract][Full Text] [Related]
12. Multiplexed silicon photonic sensor arrays enable facile characterization of coagulation protein binding to nanodiscs with variable lipid content.
Muehl EM; Gajsiewicz JM; Medfisch SM; Wiersma ZSB; Morrissey JH; Bailey RC
J Biol Chem; 2017 Sep; 292(39):16249-16256. PubMed ID: 28801460
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor/factor VIIa complex: role of the membrane surface.
Morrissey JH; Tajkhorshid E; Sligar SG; Rienstra CM
Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S8-10. PubMed ID: 22417943
[TBL] [Abstract][Full Text] [Related]
14. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
15. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
Doñate F; Kelly CR; Ruf W; Edgington TS
Biochemistry; 2000 Sep; 39(37):11467-76. PubMed ID: 10985793
[TBL] [Abstract][Full Text] [Related]
16. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
Hathcock JJ; Rusinova E; Andree H; Nemerson Y
Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of Tissue Factor. Factor VIIa for anticoagulant therapy.
Lazarus RA; Olivero AG; Eigenbrot C; Kirchhofer D
Curr Med Chem; 2004 Sep; 11(17):2275-90. PubMed ID: 15379712
[TBL] [Abstract][Full Text] [Related]
18. Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
Krishnan R; Kotian PL; Chand P; Bantia S; Rowland S; Babu YS
Acta Crystallogr D Biol Crystallogr; 2007 Jun; 63(Pt 6):689-97. PubMed ID: 17505107
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamic simulations of the binary complex of human tissue factor (TF(1-242) ) and factor VIIa (TF(1-242) /FVIIa) on a 4:1 POPC/POPS lipid bilayer.
Lee CJ; Wu S; Bartolotti LJ; Pedersen LG
J Thromb Haemost; 2012 Nov; 10(11):2402-5. PubMed ID: 22967237
[No Abstract] [Full Text] [Related]
20. Analysis of the factor VIIa binding site on human tissue factor: effects of tissue factor mutations on the kinetics and thermodynamics of binding.
Kelley RF; Costas KE; O'Connell MP; Lazarus RA
Biochemistry; 1995 Aug; 34(33):10383-92. PubMed ID: 7654692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
